Prosecution Insights
Prosecution Insights
47 pending office actions • 31 clients • 45 examiners • 32 art units • 0 of 47 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 9 (19%) |
| §103 only | 9 (19%) |
| §102 only | 1 (2%) |
| §112 only | 2 (4%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 2 (4%) |
| Multi-statute (no §101) | 22 (47%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GAO, ASHLEY HARTMAN | 2 | 57.5% | +42.4% |
| POHNERT, STEVEN C | 2 | 12.2% | +18.7% |
| SANG, HONG | 1 | 54.7% | +62.6% |
| TAMIL, JESSICA KAVINI | 1 | 39.5% | +49.1% |
| SONG, ZHENG B | 1 | 70.1% | +15.3% |
| OUYANG, BO | 1 | 60.8% | +8.9% |
| BARNETT, JOEL | 1 | 80.6% | +12.1% |
| BOYLAN, JAMES T | 1 | 63.0% | +11.3% |
| BAUER, NICOLA MARIA | 1 | 56.6% | +47.4% |
| BURKHART, MICHAEL D | 1 | 62.2% | +11.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16985090 | Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation | DHAR, MATASHA | 743d overdue |
| 18280778 | Multi-Dose Container for Ophthalmic Compositions | FAY, ZOHREH ALEMZADEH | 119d overdue |
| 18292702 | Method And Device For Detecting Multi-Access Account By Using Similarity Degree Between Nicknames | RENWICK, REGINALD A | 31d overdue |
| 18005332 | COVID-19 Mucosal Antibody Assay | PARKIN, JEFFREY S | 30d overdue |
| 18097058 | BLOODSTREAM INFECTION DETECTION METHODS AND KITS | CROW, ROBERT THOMAS | 24d overdue |
| 18589965 | Stackable Tower with Hollow Pieces | DAVISON, LAURA L | 3d overdue |
| 18011664 | Methods For Reducing Catecholamine-Formaldehyde Adducts | YOUNG, MICAH PAUL | 15d |
| 18877250 | Optical Display Device | SONG, ZHENG B | 20d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18715883 | UV SYSTEM AND METHODS FOR GENERATING AN ALPHA CHANNEL | BOYLAN, JAMES T | 15d overdue |
| 16961026 | Fusion Protein Extensions | GAO, ASHLEY HARTMAN | 5d |
| 18877250 | Optical Display Device | SONG, ZHENG B | 20d |
| 19061787 | Collapsible Container | TAMIL, JESSICA KAVINI | 27d |
| 18860584 | Cabin Power Distribution Systems and Methods | BARNETT, JOEL | 39d |
| 19399287 | NK-92 Cells with Cytokine Induced Memory-Like Cytotoxicity And Derivatives Thereof | SANG, HONG | — |
| 18709448 | METHOD FOR SYNTHESIZING RIVAROXABAN | BAUER, NICOLA MARIA | — |
| 18658913 | Reprogrammed T Cell-Like NK Cells | BURKHART, MICHAEL D | — |
| Art Unit | Apps |
|---|---|
| 1683 | 3 |
| 1675 | 2 |
| 1794 | 2 |
| 3791 | 2 |
| 1678 | 2 |
| 1646 | 1 |
| 3733 | 1 |
| 2875 | 1 |
| 2849 | 1 |
| 2486 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19399287 | NK-92 Cells with Cytokine Induced Memory-Like Cytotoxicity And Derivatives Thereof | Immunitybio, Inc. | SANG, HONG | 1646 | §102§112 | Final Rejection | — | Pending | Nov 24, 2025 |
| 19061787 | Collapsible Container | Clevermade, LLC | TAMIL, JESSICA KAVINI | 3733 | §102§103§112 | Non-Final OA | 27d | Pending | Feb 24, 2025 |
| 18877250 | Optical Display Device | Innerscene Limited | SONG, ZHENG B | 2875 | §102§103 | Final Rejection | 20d | Pending | Dec 19, 2024 |
| 18868726 | Surgical Assembly and System | Alesi Surgical Limited | OUYANG, BO | §103 | Non-Final OA | — | Pending | Nov 22, 2024 | |
| 18860584 | Cabin Power Distribution Systems and Methods | Rave Aerospace, LLC | BARNETT, JOEL | 2849 | §103§112 | Non-Final OA | 39d | Pending | Oct 25, 2024 |
| 18715883 | UV SYSTEM AND METHODS FOR GENERATING AN ALPHA CHANNEL | The Invisible Pixel Inc. | BOYLAN, JAMES T | 2486 | §103 | Final Rejection | 15d overdue | Pending | Jun 03, 2024 |
| 18709448 | METHOD FOR SYNTHESIZING RIVAROXABAN | Zhejiang Huahai Licheng Pharmaceutical Co., Ltd. | BAUER, NICOLA MARIA | §103§112 | Non-Final OA | — | Pending | May 10, 2024 | |
| 18658913 | Reprogrammed T Cell-Like NK Cells | Nantbio, Inc. | BURKHART, MICHAEL D | §102§103 | Non-Final OA | — | Pending | May 08, 2024 | |
| 18646642 | Compositions And Methods For Prevention And Reduction Of Traumatic Brain Injury | Rob D. Dickerman | SCHMITT, MICHAEL J | 1629 | §102§103DP | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18702191 | Improvements to a Cable Drum | Afik Group P.K Ltd. | MCCARRY JR, ROBERT J | §102 | Non-Final OA | — | Pending | Apr 17, 2024 | |
| 18614525 | OPTICAL DISPLAY DEVICE | Innerscene Limited | OSINSKI, MICHAEL S | 2674 | §102§103 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18609750 | Oolitic Aragonite Beads and Methods Therefor | Nant Holdings Ip, LLC | ATKINSON, JOSHUA ALEXANDER | 1612 | DP | Non-Final OA | — | Pending | Mar 19, 2024 |
| 18693129 | COMPOSITION AND COMPOSITE ARTICLE FOR FORMING NITRIC OXIDE | Sterile State, LLC | CHEN, CHANGRU | 1796 | §103 | Non-Final OA | — | Pending | Mar 18, 2024 |
| 18606693 | BIO-RESORBABLE ORTHOPAEDIC LAG SCREW FOR SMALL BONE FRACTURE FIXATION | Biocomposites Limited | COLEY, ZADE JAMES | 3775 | §102§103§112 | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18589965 | Stackable Tower with Hollow Pieces | UT Brands LLC | DAVISON, LAURA L | 3993 | §101§102§103§112 | Non-Final OA | 3d overdue | Pending | Feb 28, 2024 |
| 18292864 | Method And Device For User Information Prediction Using Play Log | Kakao Games Corp. | WASAFF, JOHN S. | §101§102§103§112 | Non-Final OA | — | Pending | Jan 26, 2024 | |
| 18292702 | Method And Device For Detecting Multi-Access Account By Using Similarity Degree Between Nicknames | Kakao Games Corp. | RENWICK, REGINALD A | 3715 | §101 | Final Rejection | 31d overdue | Pending | Jan 26, 2024 |
| 18522074 | Systems And Methods For Genetic Analysis Of Metastases | Nantomics LLC | SULLIVAN, DENNIS JOHN | §101§112DP | Non-Final OA | — | Pending | Nov 28, 2023 | |
| 18504406 | Method And Apparatus For Providing Dart Game Using Artificial Intelligent Technology | Phoenixdarts Co., Ltd. | WEISS, NICHOLAS J | 3711 | §103§112 | Non-Final OA | — | Pending | Nov 08, 2023 |
| 18559682 | Polymorph Of Imidazolidinone Compound, Preparation Method Therefor And Use Thereof | BETTA PHARMACEUTICALS CO., LTD | HEASLEY, MEGHAN CHRISTINE | 1626 | §112 | Non-Final OA | 28d overdue | Pending | Nov 08, 2023 |
| 18280778 | Multi-Dose Container for Ophthalmic Compositions | Vyluma Inc. | FAY, ZOHREH ALEMZADEH | 1617 | §103§112 | Non-Final OA | 119d overdue | Pending | Sep 07, 2023 |
| 18278797 | Highly Potent M-CENK Cells And Methods | Immunitybio, Inc. | BENAVIDES, JENNIFER ANN | 1675 | §103§112 | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18450643 | Method, Computer Program, And Device For Generating Training Dataset To Identify Hit Location Of Dart Pin | Phoenixdarts Co., Ltd. | NGUYEN, LEON VIET Q | 2663 | §103 | Final Rejection | 3d overdue | Pending | Aug 16, 2023 |
| 18256597 | Organic Compound And Organic Light-Emitting Device Comprising Same | P&H Tech Co., Ltd. | FORTWENGLER, JAMES RICHARD | §102§103 | Non-Final OA | — | Pending | Jun 08, 2023 | |
| 18265601 | LESION DIAGNOSIS METHOD | Vuno Inc. | TRAN, TAN H | 2141 | §101§103 | Final Rejection | — | Pending | Jun 06, 2023 |
| 18330246 | Systems And Methods For Aqueous Recovery Of Lead From Lead Acid Batteries With Reduced Electrolyte Demand | Aqua Metals Inc. | MENDEZ, ZULMARIAM | 1794 | §102§103 | Non-Final OA | — | Pending | Jun 06, 2023 |
| 18038934 | Optical Device Having Monolithic Architecture And Method For Manufacturing Same | Deep-In-Sight Co., Ltd. | BAGHDASARYAN, HOVHANNES | 3645 | §103 | Final Rejection | 16d overdue | Pending | May 25, 2023 |
| 18248855 | New Drug Prediction Method, And Apparatus For Performing Method | Deargen Inc. | LUO, JAMMY NMN | §101§103 | Non-Final OA | — | Pending | Apr 12, 2023 | |
| 18044892 | Neural Interface | Imperial College Innovations Limited | TOTH, KAREN E | 3791 | §101§102§103§112 | Final Rejection | — | Pending | Mar 10, 2023 |
| 18043276 | Genetic Construct | Instituto De Medicina Molecular João Lobo Antunes | MCCORMICK, CATHERINE LYNN | 1638 | §102§103 | Non-Final OA | 40d | Pending | Feb 27, 2023 |
| 18097058 | BLOODSTREAM INFECTION DETECTION METHODS AND KITS | Suzhou Precigenome Ltd. Co. | CROW, ROBERT THOMAS | 1683 | §103§112Other | Non-Final OA | 24d overdue | Pending | Jan 13, 2023 |
| 18005332 | COVID-19 Mucosal Antibody Assay | Nantcell, Inc. | PARKIN, JEFFREY S | 1671 | §103§112 | Non-Final OA | 30d overdue | Pending | Jan 12, 2023 |
| 18011664 | Methods For Reducing Catecholamine-Formaldehyde Adducts | Nevakar Injectables Inc. | YOUNG, MICAH PAUL | 1618 | §103§112 | Non-Final OA | 15d | Pending | Dec 20, 2022 |
| 17999087 | T Cells | Instituto De Medicina Molecular João Lobo Antunes | WESTON, ALYSSA G | 1633 | §102§103 | Non-Final OA | — | Pending | Nov 17, 2022 |
| 17922678 | PROCESSING 1H-NMR SPECTRAL DATA | Imperial College Innovations Limited | LEE, BYUNG RO | 2858 | §101§103 | Non-Final OA | 34d | Pending | Nov 01, 2022 |
| 17932633 | Modified EC7 Cells Having Low Toxicity to Viral Production Payloads | Nantbio, Inc. | MARVICH, MARIA | §112 | Non-Final OA | — | Pending | Sep 15, 2022 | |
| 17874747 | GRAPHENE NANOPLATELET BATTERIES, APPARATUS, AND COMPOSITIONS | Directa Plus, S.p.A. | MARTIN, ANGELA J | 1727 | §103 | Final Rejection | — | Pending | Jul 27, 2022 |
| 17843247 | Cancer Neoepitopes | Nant Holdings Ip, LLC | GAO, ASHLEY HARTMAN | 1678 | §103§112Other | Non-Final OA | — | Pending | Jun 17, 2022 |
| 17720624 | Compositions and Methods for Targeted NGS Sequencing of cfRNA and cfTNA | Genomic Testing Cooperative, Lca | POHNERT, STEVEN C | 1683 | §101§103§112 | Final Rejection | — | Pending | Apr 14, 2022 |
| 17697781 | Techniques For Performing Subject Word Classification Of Document Data | Tmaxtibero Co., Ltd. | OPSASNICK, MICHAEL N | 2658 | §102§103 | Final Rejection | 72d | Pending | Mar 17, 2022 |
| 17631844 | Metal Recovery From Lead Containing Electrolytes | Aqua Metals Inc. | WILKINS III, HARRY D | 1794 | §103 | Final Rejection | — | Pending | Jan 31, 2022 |
| 17482816 | Compositions and Methods for Targeted NGS Sequencing of cfRNA and cfTNA | Genomic Testing Cooperative, Lca | POHNERT, STEVEN C | 1683 | §103§112 | Final Rejection | — | Pending | Sep 23, 2021 |
| 17270361 | Neural Interface | University Of Maribor | PORTILLO, JAIRO H | 3791 | §103 | Non-Final OA | — | Pending | Feb 22, 2021 |
| 16961026 | Fusion Protein Extensions | Nantbio, Inc. | GAO, ASHLEY HARTMAN | 1678 | §103 | Final Rejection | 5d | Pending | Oct 15, 2020 |
| 16985090 | Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation | Immunitybio, Inc. | DHAR, MATASHA | 1632 | §103§112 | Non-Final OA | 743d overdue | Pending | Aug 04, 2020 |
| 16718023 | Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity | Juvn3 Holdings, LLC | LEE, SIN J | 1613 | §103DP | Final Rejection | — | Pending | Dec 17, 2019 |
| 16576415 | SAMPLE DESTRUCTION VALIDATION SYSTEM AND METHODS | Immunitybio, Inc. | FONTAINHAS, AURORA M | 1675 | §101§112 | Non-Final OA | — | Pending | Sep 19, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial